Skip to content

Home Map The News Technology Politics Business Sports Entertainment Science Health World

Global AI-Powered News Intelligence. Real-time headlines, mapped by continent and country, from authoritative sources worldwide.

Powered by AI

Navigate

Home
Map The News
About
Search

Sections

Technology
Politics
Business
Sports
Entertainment
Science

More

Privacy
Contact
Sitemap
Robots

© 2026 newsGlobal. All rights reserved.

Headlines refresh every 10 minutes.

Home Map Search Topics About

Home / Business

AstraZeneca's Rare Drug Trial Failure Sends Shares Plunging

Bloomberg

BusinessBloomberg·Jul 9, 2026·1 min read

AstraZeneca's Rare Drug Trial Failure Sends Shares Plunging

AstraZeneca Plc's shares dropped more than 10% after a trial of a new heart drug failed to help prevent heart problems in patients with a rare disease. Bloomberg Intelligence's Sam Fazeli has more on "Bloomberg Open Interest." (Source: Bloomberg)

View original source — Bloomberg ↗

ShareShare on X Share on Facebook

Related stories

Trump Stops in UK to Switch Air Force One Planes (Video)

BusinessJul 9, 2026 · 1 min

Trump Stops in UK to Switch Air Force One Planes (Video)

Cramer defends a struggling tech giant and says another stock could soon be a buy

BusinessJul 9, 2026 · 1 min

Cramer defends a struggling tech giant and says another stock could soon be a buy

Bitcoin-Backed Muni Bond Fails to Get New Hampshire Sign Off

BusinessJul 9, 2026 · 1 min

Bitcoin-Backed Muni Bond Fails to Get New Hampshire Sign Off

Russia’s budget deficit totals 2.5% of GDP in January-June — ministry

BusinessJul 9, 2026 · 1 min

Russia’s budget deficit totals 2.5% of GDP in January-June — ministry